This article was originally published in Fast Company.
What does it meant to take a Corporate Venture Capital (CVC) approach to personal investing as it pertains to energy transition trends?
Typically, CVC groups within large corporates have the dual objectives of achieving financial returns and securing access to emerging technologies and business models that are likely to impact or disrupt the corporate’s core markets. By virtue of establishing a CVC and entering the pool of potential investors that startups call on for fundraising, corporates get access to market intelligence—even if they decline to invest.
Recently, Energy Managing Director Julie McLaughlin wrote an article on how to leverage CVC investments and set yourself up for success.
Read the full article.
Digital Deception: Fighting Fraud in the Era of Emerging Technology
August 26, 2025
Davin Teo and Henry Chambers, Managing Directors and Co-leaders of Disputes and Investigations Asia wrote an article on digital deception for the Hong Kong Chartered Governance Institute’s CGj August 2025 issue.
Unlocking Federal Real Estate: Efficiency, Partnerships, and the Path Ahead
August 26, 2025
Managing Director Tom Scott and Senior Director Paul Firth, join George Guszcza, President & CEO of the National Institute of Building Sciences, on The GovNavigators Show to discuss trends, challenges, and opportunities shaping the future of federal real estate.
DOJ and HHS collaborate to enhance False Claims Act prosecution
August 25, 2025
In a recent article for Westlaw Today, Managing Directors Jenelle Beavers and Donald Lochabay explore the U.S. government’s new collaboration and enforcement priorities around the False Claims Act (FCA).
Next-Generation Antibodies: A New Era in Immuno-Oncology
August 25, 2025
As the immune checkpoint inhibitor (ICI) market nears a patent cliff, the $50B immuno-oncology (IO) field is now seeking to surpass the limitations of earlier ICIs by enhancing survival outcomes, broadening coverage, and overcoming resistance mechanisms.
